cinvanti
Generic: aprepitant
cinvanti: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | Approved |
FDA Decisions
Approval(HRTX)
Frequently asked questions
Who is developing cinvanti?
cinvanti is being developed by HERON THERAPEUTICS, INC. /DE/.
What is cinvanti's latest FDA decision?
The most recent tracked FDA decision for cinvanti is Approval, dated November 9, 2017.
Get deeper analysis on cinvanti
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis